adplus-dvertising
Connect with us

Business

COVID-19 vaccine: experts call for injury compensation program – CTV News

Published

 on


TORONTO —
Canada may be at the forefront of the race to develop an effective COVID-19 vaccine, with a clinical trial already approved, but experts warn we have fallen short in developing a fund to compensate those who may be injured by vaccinations.

With immense political and public pressure to develop a vaccine, a process that can take years, researchers are carrying out trials at an unprecedented pace in efforts to bring a successful vaccine to market in a matter of months.

And although vaccine-related reactions are rare, experts say a new vaccine — especially one developed using new technology — may come with unknown risks.

At least 19 countries already have programs in place that compensate individuals injured by vaccines, but Canada does not.

In fact, it is the only G7 country without such measures in place, and experts are now calling on the federal government to prepare in advance of the COVID-19 vaccination program.

“If you do suffer an adverse event, a serious adverse event, one of those very rare events, you should be compensated,” said Jennifer Keelan, a retired researcher who worked at the University of Toronto’s Department of Public Health, told CTV News. 

“An ideal process is to think about these things before you implement the mass vaccine program, rather than reacting.”

Adverse reactions to vaccines are rare, but have had deadly repercussions in the past.

In 1976, the U.S. government rushed to develop a swine flu vaccination over fears of the next big pandemic. The immunization program was halted after 10 weeks due to reports that the vaccination increased the risk for Guillain-Barre syndrome (GBS), a rare form of paralysis that starts in the feet and creeps up the body.

Though the associated risk was approximately one in 100,000, more than 450 people developed GBS after receiving the vaccine. Of those, 25 died.

Similarly, in 2009, the H1N1 influenza vaccine, while largely deemed safe, was linked with cases of narcolepsy in Europe.

Experts warn that vaccine manufacturers may demand legal protection against lawsuits regarding adverse reactions to a new vaccine.

In 2009, the Canadian government put forth an emergency process to release the H1N1 vaccine without waiting for Health Canada to review the results of clinical trials concerning the vaccine’s efficacy.

According to the Canadian Medical Association Journal, Canada agreed to indemnify the vaccine’s manufacturer, Glaxo-SmithKline, from potential lawsuits.

At the time, the federal government was said to be considering a no-fault compensation scheme, or a vaccine injury compensation program. However, no such program was ever created.

Quebec is the only province that offers such a plan for adverse reactions stemming from immunizations.

In other provinces and territories, any healthcare costs associated with an adverse vaccine reaction would be covered through the public health system or, if disability occurred, through disability income.

According to the Canadian Vaccination Evidence Resource and Exchange Centre, the only other recourse would be through litigation. However, there is a limited understanding of the number of vaccine-injury related lawsuits in Canada.

CTV News contacted the federal government to see if there was any consideration for such a program in light of the circumstances surrounding COVID-19. A request for comment was not returned.

“Some of these individuals may actually be front-line workers, personal support workers, health-care workers, or those working in long-term care centres who will be asked to receive this vaccine not only for their benefit, but to protect the patients, the people they are caring for,” Dr. Kumanan Wilson, senior scientist at the Ottawa Hospital Research Institute, told CTV News.

“Despite best practices being taken, if these individuals are harmed, we need a system in place to help compensate them in the event of injury.”

Wilson and Keelan have been calling for Canada to implement a vaccine injury compensation program for nearly 10 years.

In a 2011 report for the University of Toronto’s Munk School of Global Affairs, the researchers noted that, “the history and experience with vaccine-related injuries in many other western countries also suggests that it is highly probable that Canada will be faced with circumstances.”

At the time, Keelan noted that a no-fault compensation program for vaccine-related injuries would not only benefit people who suffer harm, it might also give those who are waffling about whether to get a vaccine the incentive they need to go ahead.

“We want people to be vaccinated. Vaccines are incredibly safe and they are one of the most effective public health measures that we have for preventing vaccine-preventable diseases,” she said in a 2011 interview with CTVNews.ca.

“We want them to have confidence in our publicly funded vaccine.”​ 

Let’s block ads! (Why?)

728x90x4

Source link

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending